![Kathleen Glaub](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Glaub
Fondateur chez
CuraSen Therapeutics, Inc.
Fortune : - $ au 30/06/2026
Profil
Kathleen Sereda Glaub is the founder of CuraSen Therapeutics, Inc., founded in 2016, serving as Chief Executive Officer & Director since 2016.
Current job includes Director at IO Biotech ApS since 2018.
Former jobs include Chief Executive Officer & Director at Afferent Pharmaceuticals, Inc. from 2014 to 2016; Independent Director at Codexis, Inc. from 2014 to 2019; Independent Director at Aligos Therapeutics, Inc.; Independent Director at Escient Pharmaceuticals, Inc.; Independent Director at IO Biotech, Inc. from 2018 to 2026; Chief Financial Officer & Senior Vice President at Cell Genesys, Inc.; Treasurer at Genentech, Inc.; Principal at Intel Corp.; and President at Plexxikon, Inc. from 2001 to 2013.
Education includes undergraduate degree from the University of California, Berkeley and MBAistration from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IO BIOTECH, INC. -.--% | 05/06/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Kathleen Glaub
| Sociétés | Poste | Début |
|---|---|---|
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies | Directeur/Membre du Conseil | 11/06/2018 |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Fondateur | 18/04/2016 |
Anciens postes connus de Kathleen Glaub
| Sociétés | Poste | Fin |
|---|---|---|
| IO BIOTECH, INC. | Directeur/Membre du Conseil | 31/03/2026 |
| CODEXIS, INC. | Directeur/Membre du Conseil | 30/09/2019 |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Directeur Général | 01/07/2016 |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | President | 01/05/2013 |
| ALIGOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Kathleen Glaub
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Intel Corp.
 Intel Corp. SemiconductorsElectronic Technology Engages in design, development, manufacture and sale of CPUs and integrated circuits to computing and related end products | Electronic Technology |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies | Health Technology |
CuraSen Therapeutics, Inc.
CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Health Technology |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
